VCT vs. JMAT, ELM, SCPA, ESNT, SYNT, TET, ZTF, IOF, WCH, and ITX
Should you be buying Victrex stock or one of its competitors? The main competitors of Victrex include Johnson Matthey (JMAT), Elementis (ELM), Scapa Group (SCPA), Essentra (ESNT), Synthomer (SYNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), and Itaconix (ITX). These companies are all part of the "specialty chemicals" industry.
Victrex vs.
Victrex (LON:VCT) and Johnson Matthey (LON:JMAT) are both basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.
Victrex received 21 more outperform votes than Johnson Matthey when rated by MarketBeat users. Likewise, 63.61% of users gave Victrex an outperform vote while only 61.99% of users gave Johnson Matthey an outperform vote.
In the previous week, Victrex had 1 more articles in the media than Johnson Matthey. MarketBeat recorded 1 mentions for Victrex and 0 mentions for Johnson Matthey. Victrex's average media sentiment score of 1.07 beat Johnson Matthey's score of 0.91 indicating that Victrex is being referred to more favorably in the media.
Victrex has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Johnson Matthey has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500.
Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 7.7%. Johnson Matthey pays an annual dividend of GBX 77 per share and has a dividend yield of 5.6%. Victrex pays out 170.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Johnson Matthey pays out 130.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Victrex presently has a consensus price target of GBX 1,170, suggesting a potential upside of 49.23%. Johnson Matthey has a consensus price target of GBX 1,900, suggesting a potential upside of 37.26%. Given Victrex's higher probable upside, analysts plainly believe Victrex is more favorable than Johnson Matthey.
Victrex has a net margin of 10.81% compared to Johnson Matthey's net margin of 0.84%. Victrex's return on equity of 6.67% beat Johnson Matthey's return on equity.
Johnson Matthey has higher revenue and earnings than Victrex. Victrex is trading at a lower price-to-earnings ratio than Johnson Matthey, indicating that it is currently the more affordable of the two stocks.
97.1% of Victrex shares are owned by institutional investors. Comparatively, 66.6% of Johnson Matthey shares are owned by institutional investors. 1.6% of Victrex shares are owned by company insiders. Comparatively, 0.6% of Johnson Matthey shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Victrex beats Johnson Matthey on 12 of the 20 factors compared between the two stocks.
Get Victrex News Delivered to You Automatically
Sign up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (LON:VCT) was last updated on 5/22/2025 by MarketBeat.com Staff